In vitro antiglycation activity of Eremurus persicus (Jaub. Et Sp.) Boiss

13Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia and long-term complications affecting the eyes, nerves, blood vessels, skin and kidneys. Increased glycation of proteins and accumulation of advanced glycation endproducts (AGEPs) have been implicated in the pathogenesis of diabetic complications. Glycation and AGEP formation are also accompanied by the formation of free radicals via autoxidation of glucose and glycated proteins. Since this plant Eremurus persicus is used as an antidiabetic agent in Iranian traditional medicine, we were prompted to evaluate the antiglycation activity of this species. Here, we reported the isolation of a known compound, 5,6,7- trimethoxy-coumarin for the first time for the antiglycation properties of this plant. © 2011 Academic Journals.

Cite

CITATION STYLE

APA

Asgarpanah, J., Amin, G., & Parviz, M. (2011). In vitro antiglycation activity of Eremurus persicus (Jaub. Et Sp.) Boiss. African Journal of Biotechnology, 10(54), 11287–11289. https://doi.org/10.5897/ajb11.672

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free